4.4 Article

The SNHG16/miR-30a axis promotes breast cancer cell proliferation and invasion by regulating RRM2

Journal

NEOPLASMA
Volume 67, Issue 3, Pages 567-575

Publisher

AEPRESS SRO
DOI: 10.4149/neo_2020_190625N550

Keywords

lncRNA SNHG16; breast cancer; miR-30a; ribonucleotide reductase M2; proliferation; invasion

Categories

Funding

  1. Zibo key research and development plan [2018kj010140]
  2. Project of Shandong Province Higher Educational Science and Technology Program [J18KA299]
  3. National Natural Science Foundation of China [81602330]

Ask authors/readers for more resources

Long noncoding RNAs (lncRNAs) have been suggested to play vital roles in tumor initiation and progression. Recent studies have reported that the IncRNA small nudeolar RNA host gene 16 (SNHG16) is highly expressed in breast cancer tissue. In the present study, we demonstrated that SNHG16 is an oncogene involved in cell proliferation and invasion in breast cancer. First, we examined the functional role of SNHG16 in breast cancer cells by knocking down SNHG16 expression via siRNA. We found that SNHG16 inhibition reduced the proliferation and invasion of breast cancer cells in vitro. Then, based on bioinformatic prediction and functional assay validation, we demonstrated SNHG16 interaction with miR-30a and its role in breast cancer cells. Finally, we examined the functional role of RRM2 in breast cancer cells by knocking down RRM2 expression via siRNA. Our results indicated that the SNHG16/miR-30a axis regulated the expression of ribonucleotide reductase M2 (RRM2) in breast cancer cells. These results provide novel insight into breast cancer tumorigenesis and suggest that SNHG16 could serve as a therapeutic target in breast cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available